Opexa Therapeutics (OPXA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OPXA | ACXP | CUPR | ||
| Company | Opexa Therapeutics | Acurx Pharmaceuticals Inc | Cuprina Holdings [Cayman] Limited | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.15 | 1.7500 | 2.75 | ||
| High | 1.16 | 1.8000 | 2.91 | ||
| Low | 0.96 | 1.7203 | 2.69 | ||
| Latest | 0.97 | 1.7700 | 2.73 | ||
| Change | -0.10 | +0.0200 | -0.10 | ||
| % Change | -9.35% | +1.14% | -3.53% | ||
| Volume | 307,200 | 35,500 | 88,500 | ||
| 20-Day Average Volume | 233,245 | 109,000 | 311,127 | ||
| Previous Close | 1.07 | 1.7500 | 2.83 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.93 | 1.9455 | 2.33 | ||
| 20-Day Raw Stochastic | 47.22% | 10.00% | 50.00% | ||
| 20-Day Relative Strength | 54.95 | 39.83 | 53.15 | ||
| Weighted Alpha | -17.12 | -93.69 | -74.27 | ||
| Today's Opinion | N/A | 100% Sell | 56% Sell | ||
| Previous Opinion | N/A | 100% Sell | 56% Sell | ||
| Last Month's Opinion | N/A | 88% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.02% since 09/13/17 | -11.06% since 05/28/26 | -17.27% since 05/28/26 | ||
| Low | 0.96 on 09/20/17 | 1.7200 on 06/03/26 | 2.21 on 05/29/26 | ||
| High | 1.16 on 09/20/17 | 2.0100 on 05/29/26 | 2.91 on 06/04/26 | ||
| 1-Month | |||||
| %Chg | +29.33% since 08/18/17 | -16.90% since 05/04/26 | +30.65% since 05/04/26 | ||
| Low | 0.74 on 08/21/17 | 1.7200 on 06/03/26 | 1.76 on 05/13/26 | ||
| High | 1.16 on 09/20/17 | 2.2200 on 05/22/26 | 3.70 on 05/28/26 | ||
| 3-Month | |||||
| %Chg | +64.41% since 06/20/17 | +16.45% since 03/04/26 | -14.82% since 03/04/26 | ||
| Low | 0.55 on 06/22/17 | 1.3259 on 03/06/26 | 1.76 on 05/13/26 | ||
| High | 1.45 on 07/05/17 | 7.5392 on 03/19/26 | 5.42 on 04/07/26 | ||
| 6-Month | |||||
| %Chg | +14.12% since 03/20/17 | -49.14% since 12/04/25 | -47.50% since 12/04/25 | ||
| Low | 0.55 on 06/22/17 | 1.3259 on 03/06/26 | 1.76 on 05/13/26 | ||
| High | 1.45 on 07/05/17 | 7.5392 on 03/19/26 | 5.44 on 12/05/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,430 | 7,521 | 7,429 | ||
| Shares Outstanding, K | 7,660 | 4,298 | 2,625 | ||
| Annual Sales | 2,910,000 | 0 | 40,000 | ||
| Annual Net Income | -7,980,000 | -7,970,000 | -3,630,000 | ||
| Last Quarter Sales | 0 | 0 | N/A | ||
| Last Quarter Net Income | -930,000 | -1,680,000 | N/A | ||
| 60-Month Beta | 2.05 | -2.09 | 2.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.62 on 05/12/26 | N/A | ||
| Earnings Date | 11/13/17 | 08/10/26 | 07/27/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||